Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities.
暂无分享,去创建一个
E. Simpson | M. Hayden | B. Leavitt | A. El-Husseini | R. S. Devon | W. Tetzlaff | P. Orban | J. McCaffery | M. Metzler | M. Barbieri | K. Gerrow | C. Lam | N. Bissada | B. Leavitt | C. Schwab | L. Cao | J. R. Helm | R. Cruz-Aguado | T. Davidson | J. Witmer | Paul C. Orban | Claudia Schwab | Elizabeth M. Simpson | Alaa El-Husseini | Michael R. Hayden
[1] N. Bresolin,et al. The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. , 2006, Brain : a journal of neurology.
[2] Robert H. Brown,et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. , 2006, Human molecular genetics.
[3] Y. Kalaidzidis,et al. Rab Conversion as a Mechanism of Progression from Early to Late Endosomes , 2005, Cell.
[4] Ahmet Hoke,et al. Loss of ALS2 Function Is Insufficient to Trigger Motor Neuron Degeneration in Knock-Out Mice But Predisposes Neurons to Oxidative Stress , 2005, The Journal of Neuroscience.
[5] M. Shoji,et al. Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis , 2005, Journal of the Neurological Sciences.
[6] B. Keller,et al. Mitochondrial Ca2+ buffering in hypoglossal motoneurons from mouse , 2005, Neuroscience Letters.
[7] B. Grant,et al. Caenorhabditis elegans RME-6 is a novel regulator of RAB-5 at the clathrin-coated pit , 2005, Nature Cell Biology.
[8] M. Hayden,et al. Cross-species characterization of the ALS2 gene and analysis of its pattern of expression in development and adulthood , 2005, Neurobiology of Disease.
[9] I. Nishimoto,et al. A Rac1/Phosphatidylinositol 3-Kinase/Akt3 Anti-apoptotic Pathway, Triggered by AlsinLF, the Product of the ALS2 Gene, Antagonizes Cu/Zn-superoxide Dismutase (SOD1) Mutant-induced Motoneuronal Cell Death* , 2005, Journal of Biological Chemistry.
[10] C. Howe,et al. Long-distance retrograde neurotrophic signaling , 2005, Current Opinion in Neurobiology.
[11] J. Esteban,et al. NMDA Receptor-Dependent Activation of the Small GTPase Rab5 Drives the Removal of Synaptic AMPA Receptors during Hippocampal LTD , 2005, Neuron.
[12] S. Hadano,et al. ALS2CL, the novel protein highly homologous to the carboxy‐terminal half of ALS2, binds to Rab5 and modulates endosome dynamics , 2004, FEBS letters.
[13] L. Pelkmans,et al. Not just a sink: endosomes in control of signal transduction. , 2004, Current opinion in cell biology.
[14] Noah W. Gray,et al. Alsin Is a Rab5 and Rac1 Guanine Nucleotide Exchange Factor* , 2004, Journal of Biological Chemistry.
[15] D. Lev,et al. The first nonsense mutation in alsin results in a homogeneous phenotype of infantile‐onset ascending spastic paralysis with bulbar involvement in two siblings , 2003, Clinical genetics.
[16] F. Gage,et al. Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model , 2003, Science.
[17] Shuh Narumiya,et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. , 2003, Human molecular genetics.
[18] M. Gonzalez-Gaitan,et al. Role of Drosophila Rab5 during endosomal trafficking at the synapse and evoked neurotransmitter release , 2003, The Journal of cell biology.
[19] M. Hayden,et al. An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred , 2003, Annals of neurology.
[20] E. Bertini,et al. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. , 2002, American journal of human genetics.
[21] D. Price,et al. Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues , 2001, Neurobiology of Disease.
[22] M. Pericak-Vance,et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis , 2001, Nature Genetics.
[23] S. Scherer,et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.
[24] M. Karin,et al. The stress-induced MAP kinase p38 regulates endocytic trafficking via the GDI:Rab5 complex. , 2001, Molecular cell.
[25] Marino Zerial,et al. Rab proteins as membrane organizers , 2001, Nature Reviews Molecular Cell Biology.
[26] J. Julien,et al. Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] Anthony A. Hyman,et al. Rab5 regulates motility of early endosomes on microtubules , 1999, Nature Cell Biology.
[28] M. Azim Surani,et al. Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest , 1998, Nature Genetics.
[29] N. Morrice,et al. A novel role for Rab5–GDI in ligand sequestration into clathrin-coated pits , 1998, Current Biology.
[30] J. McCaffery,et al. Localization of GTPases by indirect immunofluorescence and immunoelectron microscopy. , 1995, Methods in enzymology.
[31] M. Colombo,et al. Rab5, an early acting endosomal GTPase, supports in vitro endosome fusion without GTP hydrolysis. , 1994, The Journal of biological chemistry.
[32] W. Brown,et al. Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis , 1993, Brain Research Bulletin.
[33] M. Zerial,et al. rab5 controls early endosome fusion in vitro , 1991, Cell.